Search Results - "E. Iacobaeus"

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study by Silfverberg, Thomas, Zjukovskaja, Christina, Ljungman, Per, Nahimi, Adjmal, Ahlstrand, Erik, Dreimane, Arta, Einarsdottir, Sigrun, Fagius, Jan, Iacobaeus, Ellen, Hägglund, Hans, Lange, Niclas, Lenhoff, Stig, Lycke, Jan, Mellergård, Johan, Piehl, Fredrik, Svenningsson, Anders, Tolf, Andreas, Cherif, Honar, Carlson, Kristina, Burman, Joachim

“…BackgroundA growing evidence base supports the use of autologous haematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple…”
Get full text

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis by TEUNISSEN, C. E, IACOBAEUS, E, JAKOBS, C, DIJKSTRA, C. D, KHADEMI, M, BRUNDIN, L, NORGREN, N, KOEL-SIMMELINK, M. J. A, SCHEPENS, M, BOUWMAN, F, TWAALFHOVEN, H. A. M, BLOM, H. J

“…Axonal degeneration is the likely cause of disease progression in multiple sclerosis (MS). Our previous results indicated that neuron-specific…”
Get full text

The risk of COVID-19 severity in patients with ms appears to be associated with immunotherapy by E. Iacobaeus, I. Boström, Ch. Zhukovsky, Sh.G. Berntsson, A.-M. Landtblom

“…Immunomodulatory drugs are important to control disease activity in relapsing-remitting multiple sclerosis (MS). Anti-CD 20-therapy is one of such medications…”
Get full text

PO.1.12 Transcriptome profiling and autoimmunity-related serological markers identify TP53 and C3aR as drug targets in neuropsychiatric systemic lupus erythematosus by Lindblom, J, Toro-Domínguez, D, Carnero-Montoro, E, Borghi, MO, Castillo, J, Iacobaeus, E, Enman, Y, Repsilber, D, Mohan, C, Alarcón-Riquelme, M, Barturen, G, Parodis, I

“…PurposeInvolvement of the nervous system is a common but poorly understood manifestation of systemic lupus erythematosus (SLE), termed neuropsychiatric SLE…”
Get full text

Brain endothelial cell expression of SPARCL‐1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro by Bridel, C., Koel‐Simmelink, M. J. A., Peferoen, L., Derada Troletti, C., Durieux, S., Gorter, R., Nutma, E., Gami, P., Iacobaeus, E., Brundin, L., Kuhle, J., Vrenken, H., Killestein, J., Piersma, S. R., Pham, T. V., De Vries, H. E., Amor, S., Jimenez, C. R., Teunissen, C. E.

“…Aims Cell matrix modulating protein SPARCL‐1 is highly expressed by astrocytes during CNS development and following acute CNS damage. Applying NanoLC‐MS/MS to…”
Get full text

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA by Iacobaeus, E, Ryschkewitsch, C, Gravell, M, Khademi, M, Wallstrom, E, Olsson, T, Brundin, L, Major, EO

“…Objective 1) To determine whether JC virus (JCV) DNA was present in the cerebrospinal fluid (CSF) and blood from patients with multiple sclerosis (MS) in…”
Get full text

Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents by Iacobaeus, E, Hopia, L, Khademi, M, Lundén, M, Hammarin, A-L, Svenungsson, E, Andersson, M

“…Objective The objective of this report is to assess the presence and viral load of JC polyomavirus (JCV) DNA in cerebrospinal fluid (CSF) and plasma from…”
Get full text

Neurological follow up and management of disease reactivation following aHSCT by Iacobaeus, E

Get full text

Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis by Vogt, M H J, Teunissen, C E, Iacobaeus, E, Heijnen, D A M, Breij, E C W, Olsson, T, Brundin, L, Killestein, J, Dijkstra, Christine D

“…Objective:Recent studies reported contrasting results with respect to the presence of anti-myelin protein antibodies in multiple sclerosis (MS) and their…”
Get full text

The national incidence of PML in Sweden, 1988-2013 by Iacobaeus, E

Get full text

Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis by Di Marco, R., Khademi, M., Wallstrom, E., Iacobaeus, E., Salvaggio, A., Caracappa, S., Papoian, R., Nicoletti, F., Olsson, T.

“…We have studied the effects of treatment with recombinant human (rh)IL-6 on clinical, histological and immunological parameters of protracted relapsing (PR)…”
Get full text

Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study by Mouresan, Elena F, Mentesidou, Eleni, Berglund, Anders, McKay, Kyla A, Hillert, Jan, Iacobaeus, Ellen

“…Clinical onset of multiple sclerosis (MS) after the age of 50 years is uncommon and associated with a less favorable natural history. The differences in…”
Get full text

Autologous hematopoietic stem cell transplantation in relapsing remitting multiple sclerosis patients:. single centre experience by Mavromati, S, Brundin, L, Iacobaeus, E

Get full text

Current perspectives on mesenchymal stromal cell therapy for graft versus host disease by Kadri, Nadir, Amu, Sylvie, Iacobaeus, Ellen, Boberg, Erik, Le Blanc, Katarina

“…Graft versus host disease (GvHD) is the clinical condition in which bone marrow-derived mesenchymal stromal cells (MSCs) have been most frequently studied. In…”
Get full text

Cell-based therapeutic strategies for multiple sclerosis by Scolding, Neil J, Pasquini, Marcelo, Reingold, Stephen C, Cohen, Jeffrey A

“…The availability of multiple disease-modifying medications with regulatory approval to treat multiple sclerosis illustrates the substantial progress made in…”
Get full text

Smouldering multiple sclerosis: the ‘real MS’ by Giovannoni, Gavin, Popescu, Veronica, Wuerfel, Jens, Hellwig, Kerstin, Iacobaeus, Ellen, Jensen, Michael B., García-Domínguez, José Manuel, Sousa, Livia, De Rossi, Nicola, Hupperts, Raymond, Fenu, Giuseppe, Bodini, Benedetta, Kuusisto, Hanna-Maija, Stankoff, Bruno, Lycke, Jan, Airas, Laura, Granziera, Cristina, Scalfari, Antonio

“…Using a philosophical approach or deductive reasoning, we challenge the dominant clinico-radiological worldview that defines multiple sclerosis (MS) as a focal…”
Get full text

Frequency of severe infections and correlation with immune markers in patients with neuromyelitis optica spectrum disorders treated with rituximab: a Swedish cohort study by Carlsson, O, Jonsson, DI, Brundin, L, Iacobaeus, E

Get full text

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience by Burman, Joachim, Iacobaeus, Ellen, Svenningsson, Anders, Lycke, Jan, Gunnarsson, Martin, Nilsson, Petra, Vrethem, Magnus, Fredrikson, Sten, Martin, Claes, Sandstedt, Anna, Uggla, Bertil, Lenhoff, Stig, Johansson, Jan-Erik, Isaksson, Cecilia, Hägglund, Hans, Carlson, Kristina, Fagius, Jan

“…Autologous haematopoietic stem cell transplantation (HSCT) is a viable option for treatment of aggressive multiple sclerosis (MS). No randomised controlled…”
Get full text

Multiple sclerosis and COVID‐19: The Swedish experience by Landtblom, Anne‐Marie, Berntsson, Shala G., Boström, Inger, Iacobaeus, Ellen

“…The COVID‐19 pandemic has brought challenges for healthcare management of patients with multiple sclerosis (MS). Concerns regarding vulnerability to infections…”
Get full text

Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta‐analysis by Hagbohm, Caroline, Ouellette, Russell, Flanagan, Eoin P., Jonsson, Dagur I., Piehl, Fredrik, Banwell, Brenda, Wickström, Ronny, Iacobaeus, Ellen, Granberg, Tobias, Ineichen, Benjamin V.

“…Objective This study was undertaken to provide a comprehensive review of neuroimaging characteristics and corresponding clinical phenotypes of autoimmune glial…”
Get full text